Robert Glinecke

Title: Innovations of Robert Glinecke in Pharmaceutical Patents

Introduction

Robert Glinecke, an innovative inventor based in Glenside, Pennsylvania, has made significant contributions to the field of pharmaceuticals through his seven patents. His work focuses primarily on creating effective drug delivery systems, particularly in the area of sustained release formulations.

Latest Patents

Among his most notable inventions is the Pharmaceutical Sustained Release Matrix. This technology involves the creation of a homogeneous tablet or tablet layer through a wet granulation process using povidone (PVP) in alcohol as the granulating fluid. This formulation is combined with a pharmaceutical active ingredient, ethylcellulose, a wicking agent like microcrystalline cellulose, and an erosion promoter such as pregelatinized starch. The granulated mixture is then dried, milled, blended with additional dry powdered components, and compressed into tablets. The outcome is a pharmaceutical product that provides a long-lasting, slow, and incremental release of the active ingredient, ensuring better therapeutic effectiveness. Additionally, Glinecke has designed multi-layered pharmaceutical active tablets that consist of immediate release and/or sustained release layers, further advancing drug formulation techniques.

Career Highlights

Glinecke has worked with renowned companies such as McNeil AB and McNeil-PPC, Inc., where his expertise in pharmaceutical formulations has been instrumental in developing innovative products that enhance patient care and ensure reliable drug delivery.

Collaborations

Throughout his career, Glinecke collaborated with esteemed colleagues, including Galen W. Radebaugh and John L. Murtha. These professional relationships have led to fruitful exchanges of ideas and advancements in pharmaceutical sciences.

Conclusion

Robert Glinecke is a notable figure in the realm of pharmaceutical innovations, with a focus on sustained release drug formulations. His contributions through his patents have paved the way for improved therapeutic options, underscoring the importance of innovative thinking in the healthcare industry. With a career marked by significant collaborations and groundbreaking patents, Glinecke continues to be a valuable asset to the realm of pharmaceutical science.